.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Cipla
Chinese Patent Office
Fish and Richardson
Queensland Health
QuintilesIMS
Moodys
Novartis
Medtronic

Generated: November 20, 2017

DrugPatentWatch Database Preview

CARBOPLATIN - Generic Drug Details

« Back to Dashboard

What are the generic sources for carboplatin and what is the scope of carboplatin patent protection?

Carboplatin
is the generic ingredient in two branded drugs marketed by Pliva, Mylan Labs Ltd, Hospira, Gland Pharma Ltd, Sun Pharma Global, Pliva Lachema, Actavis Totowa, Fresenius Kabi Oncol, Fresenius Kabi Usa, Teva Pharms Usa, West-ward Pharms Int, Cordenpharma, Sandoz, Cipla Ltd, Watson Labs Teva, Akorn, Pharmachemie Bv, Accord Hlthcare, Corden Pharma, Sandoz Inc, Ingenus Pharms Llc, Sanja Pharms Co, Teva Parenteral, Nanjing King-friend, and Mylan Institutional, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Twelve suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for CARBOPLATIN

Medical Subject Heading (MeSH) Categories for CARBOPLATIN

Tentative approvals for CARBOPLATIN

Applicant Application No. Strength Dosage Form
u► Subscribe50MG/VIALINJECTABLE;INJECTION
u► Subscribe450MG/VIALINJECTABLE;INJECTION
u► Subscribe150MG/VIALINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)078732-003Feb 6, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Oncol
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077432-001Sep 29, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077266-004Feb 15, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Sanja Pharms Co
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)205487-003Mar 28, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
CARBOPLATIN
carboplatin
INJECTABLE;INJECTION091510-002May 29, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
CARBOPLATIN
carboplatin
INJECTABLE;INJECTION076162-003Oct 14, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Totowa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)078732-002Feb 6, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)091063-003Nov 9, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077926-002Sep 19, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)078280-002May 8, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-001Jul 14, 2003► Subscribe► Subscribe
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-004Jan 15, 2004► Subscribe► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-001Mar 3, 1989► Subscribe► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-003Mar 3, 1989► Subscribe► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-002Mar 3, 1989► Subscribe► Subscribe
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-003Jul 14, 2003► Subscribe► Subscribe
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-002Jul 14, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Moodys
Healthtrust
Farmers Insurance
Covington
US Department of Justice
Cerilliant
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot